BioSpace News Archive

H-CYTE, Inc. announced that H-CYTE has extended the expiration time of its rights offering to 5:00 PM Eastern Time on September 11, 2020 to provide additional time to accommodate shareholder orders and delays in processing.

- CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT - - CURE CEO will be a panelist at the 4@4 Forum on September 10 @4pm PDT - OXNARD, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at two upcoming virtual conferences in September. The LD 500 Virtual Conference on Friday, September 4 at 8:20amPDT/11:20pm EDT Rob Davidson, Preside

Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced the pricing of an underwritten public offering of 2,400,000 units at an offering price of $4.00 per unit. Each unit will immediately separate into one share of common stock, one Series

American Health Imaging, part of the US Radiology Specialists national radiology network, now offers state-of-the-art imaging services to patients and their referring physicians through its newest imaging center in Savannah, Georgia.

Amount Exceeds Minimum Stockholders’ Equity Requirement for Initial Listing on The Nasdaq Capital Market

U.S. Medical Equipment Consultants, Inc. (USMEDIC) engaged with VMware’s Pivotal Labs to create, test and deploy a solution that enables healthcare organizations to quickly locate and manage critical medical equipment used to care for patients with Covid-19.

Akorn, Inc., a leading specialty pharmaceutical company, announced that the United States Bankruptcy Court for the District of Delaware has approved its sale to the Company’s existing lenders.

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotechnology company in South Korea, announced today that on September 4 th , the company will present the interim data of its ongoing IO combo clinical trials at KSMO 2020. KSMO 2020 is the 13th annual conference hosted by the Korean Society of Medical On

Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the expansion of its leadership team with the appointment of two senior leaders with expertise in spatial biology and molecular pathology.

September is Dental Implant Awareness Month, sponsored by the American Academy of Implant Dentistry. This year’s theme, “Healthy Mouth, Healthy You!” focuses on the health benefits of dental implants.